Get started
Author

Thokozani Khubone

ORCID: 0000-0002-2488-6454
Observed ORCID: 0000-0002-2488-6454
OpenAlex ID: A5088561200
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis
2021 · Jienchi Dorward, Thokozani Khubone, et al. · The Lancet HIV · 320
PDF
Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study
2023 · Jienchi Dorward, Yukteshwar Sookrajh, et al. · The Lancet HIV · 72
PDF
Electronic Health Information Systems to Improve Disease Diagnosis and Management at Point-of-Care in Low and Middle Income Countries: A Narrative Review
2020 · Thokozani Khubone, Boikhutso Tlou, et al. · Diagnostics · 57
PDF
HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study
2020 · Jienchi Dorward, Yukteshwar Sookrajh, et al. · Journal of the International AIDS Society · 22
PDF
Clinical outcomes after extended 12‐month antiretroviral therapy prescriptions in a community‐based differentiated HIV service delivery programme in South Africa: a retrospective cohort study
2023 · Lara Lewis, Yukteshwar Sookrajh, et al. · Journal of the International AIDS Society · 18
PDF
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study
2023 · Kwabena Asare, Yukteshwar Sookrajh, et al. · The Lancet Global Health · 13
PDF
Differentiated service delivery for people using second‐line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu‐Natal, South Africa
2021 · Lara Lewis, Yukteshwar Sookrajh, et al. · Journal of the International AIDS Society · 12
PDF
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa
2023 · Kwabena Asare, Lara Lewis, et al. · Open Forum Infectious Diseases · 10
PDF
Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis
2025 · Kwabena Asare, Lara Lewis, et al. · BMJ Global Health · 7
PDF
Quality assessment of data for decentralised antiretroviral therapy referrals and laboratory results in the South African national electronic HIV management register TIER.Net
2026 · Lisanthini Naidu, Johan van der Molen, et al. · PLOS Global Public Health · 5
Long‐term usage patterns and clinical outcomes in a community‐based differentiated antiretroviral therapy delivery programme in South Africa
2023 · Lara Lewis, Yukteshwar Sookrajh, et al. · Journal of the International AIDS Society · 5
PDF
Trends in advanced HIV disease, treatment interruption, and viraemia in KwaZulu-Natal, South Africa
2026 · Sanele S. Mbeje, Lilishia Gounder, et al. · PLOS Global Public Health · 1
PDF
Effect of transitioning virally suppressed children and adolescents with HIV to dolutegravir-based antiretroviral therapy: emulated target trials in a large cohort in South Africa
2026 · Jennifer A. Brown, Yukteshwar Sookrajh, et al. · medRxiv
PDF
An audit assessing data quality, viral suppression, and transition to dolutegravir among children and adolescents with HIV in care at eThekwini Municipality, South Africa
2026 · Minenhle Hlabisa, Luvo Mtila, et al. · medRxiv
PDF
Brief Report: Earlier Referral to Differentiated Antiretroviral Therapy Delivery at Six Months After Initiation: A Retrospective Cohort Study in KwaZulu-Natal, South Africa
2026 · Johan S. van der Molen, Kwena Tlhaku, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Indirect Effects of HIV Differentiated Service Delivery Programmes on Quality of Clinic Care: A Retrospective Cohort Study of Clients Starting Antiretroviral Therapy
2026 · Lara Lewis, Yukteshwar Sookrajh, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Uptake and 24-month Outcomes of Dolutegravir- Versus Lopinavir-based Second-line Antiretroviral Therapy for People With HIV in South Africa: A Retrospective Cohort Study and Emulated Target Trial
2025 · Jennifer Anne Brown, Lara Lewis, et al. · Open Forum Infectious Diseases
PDF
Retrospective cohort analysis of antiretroviral therapy initiation timelines and clinical outcomes in adults with HIV and TB disease in KwaZulu-Natal, South Africa
2025 · Claudia J Jansen van Vuuren, Johan van der Molen, et al. · International Journal of STD & AIDS
Works count: 18
Citation count: 542
H-index: 8
I10-index: 8
Year
Topic
Type